Psychedelics and the Future of Health
We’re exploring the intersection of psychedelics, health care, mental health and even spirituality with a journalist who has been reporting on the topic for GeekWire, two entrepreneurs looking to capitalize on future legalization of psychedelics, and a physician scientist who uses a form of psychedelics as part of his practice of medicine and psychotherapy. Related stories COVID-19 mental health crunch puts impetus on psychedelic drug innovation, doctor says Oregon psychedelic startup tests nasal spray for PTSD, depression as legislative momentum builds With Oregon activists pushing for state-wide decriminalization of magic mushrooms for therapeutic use this year, one local startup wants to keep the momentum going. Silo Wellness, based in Springfield, Oregon, has developed a nasal spray for microdosing psilocybin meant to aid with anxiety, PTSD and depression. The company now hopes to spread the good word, offering seminars for volunteers who normally wouldn't try it on the black market to test the device in a controlled setting in Jamaica, where magic mushrooms are legal. Joining us for this discussion Mike Arnold, founder of Silo Wellness; entrepreneur and consultant Eric Boone of Cannabinovation.com; Dr. Sunil Aggarwal, an affiliate clinical assistant professor at the University of Washington School of Medicine; and journalist Anastasia Ustinova. As the deadly coronavirus pandemic continues to grow, the looming mental health crisis creates an urgent need for innovation, putting a spotlight on psychedelic-assisted treatments, says Aggarwal, the co-founder of Advanced Integrative Medical Science Institute (AIMS) in Seattle.See omnystudio.com/listener for privacy information.